This mechanism underscores the critical role of EZH2 in maintaining the balance between gene activation and repression through its modulation of histone marks, thereby offering insights into how EZH2 inhibitors might reactivate tumour suppressor genes like RB1. This evidence concerns the gene EZH2 and neoplasm.